Overview

A Trial of Lu AF82422 in Participants With Multiple System Atrophy (MSA)

Status:
RECRUITING

Trial end date:
2029-10-25

Target enrollment:

Participant gender:

Summary

The main goal of this trial is to evaluate the efficacy and safety of Lu AF82422 for the treatment of participants with Multiple System Atrophy (MSA).

Phase:

PHASE3

Details

Lead Sponsor:

H. Lundbeck A/S